Home / Hydroxocobalamin / United States
US ATC B03BA03 · updated 2 Nov 2026
Hydroxocobalamin shortage in United States
Is there a Hydroxocobalamin shortage in United States?
Yes. As of 2 Nov 2026, 2 Hydroxocobalamin products are reported short in United States, the first since 4 Nov 2024. No return date has been given. Main reason: other.
Also short in Belgium, Australia. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Cyanokit, Injection, 5 g/250mL (NDC 50633-310-11) limited | BTG International Inc. | 4 Nov 2024 | not given | Other |
| US | Hydroxocobalamin, Injection, 1000 MCG/ML, 30 ML Multi-Dose Vial (NDC 0591-2888-30) | Teva Pharmaceuticals USA, Inc. | 4 Nov 2024 | not given | Other |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).